Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (HKG:6990)

HKG:6990 Statistics

Total Valuation

HKG:6990 has a market cap or net worth of HKD 98.36 billion. The enterprise value is 93.55 billion.

Market Cap	98.36B
Enterprise Value	93.55B

Important Dates

The next estimated earnings date is Tuesday, November 18, 2025.

Earnings Date	Nov 18, 2025
Ex-Dividend Date	n/a

Share Statistics

HKG:6990 has 233.19 million shares outstanding. The number of shares has increased by 3.66% in one year.

Current Share Class	162.77M
Shares Outstanding	233.19M
Shares Change (YoY)	+3.66%
Shares Change (QoQ)	+2.09%
Owned by Insiders (%)	0.07%
Owned by Institutions (%)	10.18%
Float	85.80M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	59.81
PB Ratio	17.90
P/TBV Ratio	17.91
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-118.22
EV / Sales	56.89
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-104.42

Financial Position

The company has a current ratio of 6.57, with a Debt / Equity ratio of 0.03.

Current Ratio	6.57
Quick Ratio	6.22
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	-0.16
Interest Coverage	-180.13

Financial Efficiency

Return on equity (ROE) is -17.56% and return on invested capital (ROIC) is -11.57%.

Return on Equity (ROE)	-17.56%
Return on Assets (ROA)	-9.92%
Return on Invested Capital (ROIC)	-11.57%
Return on Capital Employed (ROCE)	-15.04%
Revenue Per Employee	879,378
Profits Per Employee	-423,174
Employee Count	1,837
Asset Turnover	0.31
Inventory Turnover	4.93

Taxes

Income Tax	-5.68M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +110.94% in the last 52 weeks. The beta is 0.79, so HKG:6990's price volatility has been lower than the market average.

Beta (5Y)	0.79
52-Week Price Change	+110.94%
50-Day Moving Average	489.16
200-Day Moving Average	339.99
Relative Strength Index (RSI)	37.36
Average Volume (20 Days)	656,057

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:6990 had revenue of HKD 1.64 billion and -791.34 million in losses. Loss per share was -3.51.

Revenue	1.64B
Gross Profit	939.03M
Operating Income	-850.92M
Pretax Income	-797.02M
Net Income	-791.34M
EBITDA	-794.32M
EBIT	-850.92M
Loss Per Share	-3.51

Balance Sheet

The company has 4.95 billion in cash and 143.64 million in debt, giving a net cash position of 4.80 billion or 20.60 per share.

Cash & Cash Equivalents	4.95B
Total Debt	143.64M
Net Cash	4.80B
Net Cash Per Share	20.60
Equity (Book Value)	5.49B
Book Value Per Share	23.56
Working Capital	4.82B

Cash Flow

In the last 12 months, operating cash flow was -804.36 million and capital expenditures -91.55 million, giving a free cash flow of -895.91 million.

Operating Cash Flow	-804.36M
Capital Expenditures	-91.55M
Free Cash Flow	-895.91M
FCF Per Share	-3.84

Margins

Gross margin is 57.10%, with operating and profit margins of -51.75% and -48.12%.

Gross Margin	57.10%
Operating Margin	-51.75%
Pretax Margin	-48.47%
Profit Margin	-48.12%
EBITDA Margin	-48.30%
EBIT Margin	-51.75%
FCF Margin	n/a

Dividends & Yields

HKG:6990 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.66%
Shareholder Yield	-3.66%
Earnings Yield	-0.80%
FCF Yield	-0.91%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

HKG:6990 has an Altman Z-Score of 28.4 and a Piotroski F-Score of 1.

Altman Z-Score	28.4
Piotroski F-Score	1